Pharmaceutical giants marketed a treatment target they helped create, and as sales of diabetes drugs soared, so did dangerous incidents of low blood sugar.
The coronavirus pummeled Americans who have diabetes because when the pandemic hit, the nation was already fighting a losing battle against the chronic disease.
